CSPCY Stock: CSPC Pharmaceutical Group Limited Stock Price, Analysis & Insights
Get live CSPCY stock price $3.60, comprehensive CSPC Pharmaceutical Group Limited stock analysis, charts, news, and expert forecast. Real-time CSPCY stock data and investment insights.
Loading chart data...
CSPC Pharmaceutical Group Limited (CSPCY) Overview
CSPC Pharmaceutical Group Limited (CSPCY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, CSPCY trades at $3.60 with a market capitalization of 10.38B . Over the past 52 weeks, CSPCY has traded between $3.45 and $5.83 , with the current price positioned at approximately 7% of this range . T...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 10.38B
- Current price: $3.60
- 52-week range: $3.45 - $5.83
- P/E ratio: 18.02
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
CSPC Pharmaceutical Group Limited, an investment holding entity established in 1992 and headquartered in Shijiazhuang, China, is actively involved in the research, development, manufacturing, and global distribution of pharmaceutical products. Its op...
Company Information
- CEO
- Lei Cai
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 21400
Contact Information
- Website
- https://www.cspc.com.hk
- Address
- No. 226 Huanghe Street
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 18.0)
✓ Lower volatility stock (Beta: 0.73) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CSPC Pharmaceutical Group Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CSPC Pharmaceutical Group Limited
- ⚠Investors should consider how CSPC Pharmaceutical Group Limited fits within their overall portfolio allocation
Market Cap
10.38B
P/E Ratio (TTM)
18.02
Beta
0.73
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CSPCY with peer companies:
- Price
- $0.56
- Market cap
- 8.90B
- Price
- $0.64
- Market cap
- 10.17B
- Price
- $23.41
- Market cap
- 9.30B
- Price
- $48.00
- Market cap
- 16.60B
- Price
- $75.22
- Market cap
- 13.14B
- Price
- $10.60
- Market cap
- 7.21B
- Price
- $8.85
- Market cap
- 8.70B
- Price
- $82.75
- Market cap
- 11.66B
- Price
- $60.00
- Market cap
- 12.21B
- Price
- $2.18
- Market cap
- 5.76B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.